A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer

NCT00620594 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Advanced Solid Tumors
Cowden Syndrome

Interventions

DRUG: BEZ235

Sponsor

Novartis Pharmaceuticals